Evidence map›Paper›PMID 24709683›Full record

ArticleJournal of neuropathology and experimental neurology2014

A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases.

Esther N Bit-Ivan, Eunran Suh, Hyung-Sub Shim, Sandra Weintraub, Bradley T Hyman, Steven E Arnold, Elisabeth McCarty-Wood, Viviana M Van Deerlin, Julie A Schneider, John Q Trojanowski and 5 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Esther N Bit-IvanFrom the Departments of Pathology (ENB-I, EHB), Psychiatry and Behavioral Science (SW), and Neurology (MM), Northwestern University; Northwestern Cognitive Neurology and Alzheimer Disease Center (SW, MM, EHB); and Rush University Medical Center (JAS), Chicago, Illinois; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania (ES, SEA, EM-W, VMVD, JQT); Department of Neurology, University of Iowa, Iowa City, Iowa (H-SS); Massachusetts General Hospital, Boston, Massachusetts (BTH, MPF); and Department of Neuroscience, Mayo Clinic Jacksonville, Jacksonville, Florida (MCB, RR).
Eunran Suh
Hyung-Sub Shim
Sandra Weintraub
Bradley T Hyman
Steven E Arnold
Elisabeth McCarty-Wood
Viviana M Van Deerlin
Julie A Schneider
John Q Trojanowski
Matthew P Frosch
Matt C Baker
Rosa Rademakers
Marsel Mesulam
Eileen H Bigio
University of Pennsylvania · USNorthwestern University · USMassachusetts General Hospital · USJacksonville College · USMayo Clinic in Florida · USRush University Medical Center · USUniversity of Iowa · US

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
Transgenic Mouse Models of Tau PathologiesP01AG017586 · NIA · UNIVERSITY OF PENNSYLVANIA · PI LEE, VIRGINIA M · 2000 to 2021
$37.3M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Christine S Ritchie · 2019 to 2026
$36.5M
UPenn ADCC Biomarker CoreP30AG010124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI XIE, SHARON XIANGWEN · 1991 to 2020
$35.1M
Neuropathology CoreP30AG013854 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BIGIO, EILEEN H. · 1996 to 2020
$28.9M
Epidemiologic Study of TDP-43 Pathology in Aging and DementiaR01AG042210 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI SCHNEIDER, JULIE A. · 2012 to 2018
$2.4M
Progranulin: Mutation and Regulation in Neurodegenerative diseaseR01NS065782 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2009 to 2012
$1.3M
NIA NIH HHS AG005134NIA NIH HHS AG010124NIA NIH HHS AG017586NIA NIH HHS P01 AG017586NIA NIH HHS P30 AG010124NIA NIH HHS P30 AG013854NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG13854NIA NIH HHS P50 AG005134NIA NIH HHS R01 AG042210NINDS NIH HHS R01 NS065782
6 · The paper itself

Abstract

Understanding of frontotemporal lobar degeneration, the underlying pathology most often linked to the clinical diagnosis of frontotemporal dementia, is rapidly increasing. Mutations in 7 known genes (MAPT, GRN, C9orf72, VCP, CHMP2B, and, rarely, TARDBP and FUS) are associated with frontotemporal dementia, and the pathologic classification of frontotemporal lobar degeneration has recently been modified to reflect these discoveries. Mutations in one of these genes (GRN), which encodes progranulin, have been implicated in up to a quarter of cases of frontotemporal lobar degeneration with TDP-43 (TAR DNA-binding protein 43)-positive inclusions; currently, there are more than 60 known pathogenic mutations of the gene. We present the clinical, pathologic, and genetic findings on 6 cases from 4 families, 5 of which were shown to have a novel GRN c.708+6_+9delTGAG mutation.

Indexed as

AgedAged, 80 and overDNA-Binding ProteinsFemaleFrontotemporal Lobar DegenerationGene Expression RegulationHumansInclusion BodiesIntercellular Signaling Peptides and ProteinsMaleMiddle AgedMutationProgranulinsDNA-Binding ProteinsGRN protein, humanIntercellular Signaling Peptides and ProteinsProgranulins

Identifiers

PMID24709683
PMCPMC4109801
OpenAlexW1996911380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.